Gut-Brain Axis: Role of Microbiota in Parkinson’s Disease and Multiple Sclerosis
Authors:
- Genaro Gabriel OrtizGOGenaro Gabriel Ortiz
- Luis H. deLDLuis H. de
- José A. Cruz-SerranoJCJosé A. Cruz-Serrano
- Erandis D. Torres-SánchezETErandis D. Torres-Sánchez
- Miriam A. Mora-NavarroMMMiriam A. Mora-Navarro
- Daniela L. C. Delgado- LaraDLDaniela L. C. Delgado- Lara
- Irma Gabriela Ortiz-VelázquezIOIrma Gabriela Ortiz-Velázquez
- Héctor González-UsigliHGHéctor González-Usigli
- Oscar K. Bitzer-QuinteroOBOscar K. Bitzer-Quintero
- Mario Mireles RamírezMRMario Mireles Ramírez
Open Access
- 6 February 2019
- book chapter
- Published by IntechOpen
Abstract
It has recently been discovered that the digestive tract is lined with about 100 million nerve cells; the digestive tract has been baptized, metaphorically speaking, as “the second brain,” which contains a multitude of neurotransmitters, viruses, and bacteria that help regulate our emotional state. This second brain, known as the enteric nervous system, is a unique anatomical unit that extends from the esophagus to the anus. Like the nervous system, it produces a whole series of psychoactive substances, such as serotonin, dopamine, and opioids for pain, and synthesizes benzodiazepines. In it, we find the microbiota: a set of microorganisms (viruses and bacteria). Together with the brain, the microbiota directly influences mood, character, or sleep. Knowledge about the possible relationship of the microbiota with frequent neurological diseases is still just beginning. Recently, possible changes in the microbiota have been linked to the onset of Parkinson’s disease (PD). Also, today, we know that there are differences between the microbiota of healthy people and people with multiple sclerosis and that these differences have also been related to the disease and its evolution.Keywords
This publication has 44 references indexed in Scilit:
- Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspectsJournal of Psychiatry and Neuroscience, 2013
- Chloroquine Treatment Enhances Regulatory T Cells and Reduces the Severity of Experimental Autoimmune EncephalomyelitisPLOS ONE, 2013
- Probiotic as a Novel Treatment Strategy Against Liver DiseaseHepatitis Monthly, 2013
- Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findingsJournal of Neurodevelopmental Disorders, 2012
- Treatment for Helicobacter pylori infection and risk of parkinson’s disease in DenmarkEuropean Journal of Neurology, 2012
- The role of gut microbiota in immune homeostasis and autoimmunityGut Microbes, 2012
- Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on BehaviorNeuropsychopharmacology, 2011
- The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept)Genes & Nutrition, 2011
- Immunopathogenesis of inflammatory bowel diseaseSelf/Nonself, 2010
- Host–Bacterial Symbiosis in Health and Disease2010